Webinar Summary
- Highlight the impact of migraine due to prevalence and disability
- Review the current understanding of migraine pathophysiology
- Explore the current treatment options for migraine
- Identify the persistent knowledge gaps in migraine
Migraine is a highly prevalent neurologic disease affecting approximately 12% of the global population, disproportionately affecting women. 1 in 5 women, 1 in 11 children, and 1 in 16 men have migraine. Migraine is a leading cause of disability worldwide. In fact, it is the #1 leading cause of years lived with disability for women in their most productive years. In the disease of migraine, people may experience severe, debilitating recurrent attacks of head pain accompanied by nausea, vomiting, sensitivity to light, sound, and movement. The pathophysiology of migraine involves complex interactions between genetic and environmental factors in the setting of abnormal neurologic function. In addition to lifestyle modifications and evidence based behavioral therapy, there are multiple medications for the acute and preventive treatment of migraine. Neuropeptides including calcitonin gene-related peptide (CGRP) and pituitary adenylate cyclase activating polypeptide play critical roles in migraine pathophysiology and have served as novel drug targets. Neuromodulation has also been another emerging treatment option. There continues to be persistent gaps in the diagnosis and treatment of migraine. Advocacy for people living with migraine focuses on increasing awareness, improving access to effective treatment options, and supporting research to better understand and manage this chronic neurologic disease.
Presenters
Amaal J. Starling
Dr. Amaal J. Starling is an Associate Professor of Neurology in the Mayo Clinic College of Medicine and Science. She is presently the Program Director for the Headache Medicine Fellowship. Dr. Starling has over 70 peer-reviewed publications related to her fields of interest which include migraine and posttraumatic headache.
Content Partners
American Physiological Society
About APS
Mission: To advance scientific discovery, understand life, and improve health. Vision: A global multidisciplinary community of scientists solving the major problems affecting life and health. Founded in 1887, the American Physiological Society is a global leader in expanding knowledge related to biological function. We connect a multidisciplinary community of nearly 10,000 scientists and educators from around the world, driving collaboration and spotlighting scientific discoveries in physiology and related disciplines. Our members are advancing treatments and cures for everything from cancer and heart disease, to obesity and addiction. They are also deepening our insight into living organisms generally, helping us to better understand how things like climate change are affecting the world around us. The Society serves this dynamic community in many ways, including:- Publishing 16 globally recognized scholarly journals and a highly-regarded book monograph series;
- Sponsoring scientific meetings and symposia that explore the frontiers of bio-medical science;
- Advocating for science-smart public policy that benefits both our members and the public;
- Bestowing hundreds of awards, grants, and fellowships that recognize scientific excellence and promise;
- Championing physiology education and educators, to support bigger discoveries and better clinical outcomes;
- And providing career resources and other career services, ensuring that all our members have a pathway to success.
Society for Women’s Health Research
As a national thought leader dedicated to advancing women’s health and promoting research on sex differences to optimize women’s health, the Society for Women’s Health Research (SWHR) plays a critical role in identifying clinical and research gaps; raising awareness of diseases, conditions, and life stages that differently, disproportionately, or exclusively affect women; and promoting policies that could positively shape health outcomes for women. Over its more than 30-year history, SWHR has been advancing women’s health through its core functions of science, policy, and education.
Scientist.com
Scientist.com is the world’s largest and first platform built for the intricacies of scientific outsourcing.
We help pharmaceutical and biotechnology organizations discover, engage, manage, and scale relationships with the providers that support every stage of the pipeline—from discovery and preclinical research to clinical development, manufacturing, medical affairs, and commercialization. Through a centralized platform, organizations can access a global network of 6,000+ providers, streamline sourcing and procurement workflows, maintain compliance, manage supplier relationships, and leverage data-driven insights to make faster, more informed decisions.
Today, Scientist.com supports more than 130 life science organizations, including 24 of the world's top 30 pharmaceutical companies, helping teams reduce operational complexity, accelerate timelines, and bring innovations to patients faster. Our mission is to make it possible to cure all human disease by 2050.
